BioSupply Trends Quarterly logo
Subscribe

Update on Child Hepatitis

Update on Child Hepatitis

An unusual uptick in pediatric hepatitis recently put the medical community on edge. Here’s what we know, why it matters and what to do to mitigate the condition going forward.

Study Finds Immunotherapy Causes Chronic Side Effects

Study Finds Immunotherapy Causes Chronic Side Effects

A recent study has found chronic immune-related side effects are common in patients with skin cancer who are treated with postsurgical Opdivo (nivolumab) or Keytruda (pembrolizumab), although for some individuals, these toxicities resolve by the 18-month mark.

IVIG May Improve Neurological Symptoms in MIS-C

IVIG May Improve Neurological Symptoms in MIS-C

Recent case series findings, as well as previous studies, show that children with multisystem inflammatory syndrome (MIS-C) who present with signs of active neurological symptoms may show improvement with intravenous immune globulin (IVIG) and corticosteroids.

Study Finds Adult Vaccines Potentially Protect Against Alzheimer’s

Study Finds Adult Vaccines Potentially Protect Against Alzheimer’s

A new study conducted at the University of Texas Health Science Center at Houston found that people who received shingles and pneumonia vaccines — along with tetanus and diphtheria — had as much as a 30 percent reduced risk of developing Alzheimer’s the most common type of dementia.

FDA Approves Pfizer’s ABRYSVO Vaccine for the Prevention of RSV

FDA Approves Pfizer’s ABRYSVO Vaccine for the Prevention of RSV

Pfizer’s ABRYSVO, a respiratory syncytial virus (RSV) vaccine, has been approved by the U.S. Food and Drug Administration for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth up to 6 months of age by active immunization of pregnant women at 32 through 36 weeks gestational age.

Mpox: Lessons Learned

Mpox Lessons Learned

The U.S. Monkeypox (mpox) public health emergency formally ended in early 2023. Yet, while mpox isn’t completely gone, the average number of daily cases has dwindled into the single digits. Still, many questions for public health officials remain.